18 withdrawn. 18 Phase 2, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 18 | Withdrawn 18 |
| Phase 1 | 6 | Withdrawn 6 |
Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Ivermectin Pill - Atopic Dermatitis | Phase 2 | Withdrawn | Stanford University | 2030-12-01 | 2024-12-02 | |
| Topical Steroids & Bacterial Decolonization for Radiation Dermatitis Bacterial decolonization, Mometasone furoate 0.1% cream, Bacterial decolonization and Mometasone furoate 0.1% cream - Radiation Dermatitis | Phase 2 | Withdrawn | Montefiore Medical Center | 2023-09-01 | 2023-12-22 | |
| Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone Naltrexone, Placebo - Atopic Dermatitis, Pruritus | Phase 2 | Withdrawn | University of Minnesota | 2022-12-31 | 2023-04-04 | |
| A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis BX005-A, Placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Withdrawn | BiomX, Inc. | 2022-05-01 | 2025-08-03 | |
| Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone Naltrexone, Placebo Cream - Atopic Dermatitis, Pruritus | Phase 2 | Withdrawn | University of Minnesota | 2020-10-01 | 2021-04-20 | |
| Moisturizer to Prevent Atopic Dermatitis Cura+ Moisturizing Cream - Dermatitis, Atopic | Phase 2 | Withdrawn | MYOR Ltd. | 2020-06-01 | 2021-01-15 | |
| Very Small Embryonic-like Stem Cells for Facial Skin Antiaging Very small embryonic-like stem cell - Stem Cell Transplant Complications, Skin Inflammation | Phase 1 / Phase 2 | Withdrawn | Fuda Cancer Hospital, Guangzhou | 2019-07-06 | 2020-10-19 | |
| A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis SAN007 Cream, Placebo - Atopic Dermatitis | Phase 2 | Withdrawn | Santalis Pharmaceuticals, Inc. | 2018-06-01 | 2019-01-17 | |
| A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis Orvepitant, Placebo - Pruritus, Atopic Dermatitis | Phase 2 | Withdrawn | Nerre Therapeutics Ltd. | 2018-05-01 | 2018-05-15 | |
| Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis Clobetasol 0.05% ointment, Placebo - Toxic Epidermal Necrolysis | Phase 1 / Phase 2 | Withdrawn | University of California, Davis | 2016-11-01 | 2019-08-09 | |
| Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients Moisturizer with each subject's own antimicrobial bacteria - Atopic Dermatitis, Eczema | Phase 2 | Withdrawn | University of California, San Diego | 2015-07-01 | 2020-11-05 | |
| Topical Infliximab in Autoimmune Eyes With Keratoprosthesis topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome | Phase 1 / Phase 2 | Withdrawn | James Chodosh, MD, MPH | 2014-11-01 | 2017-04-07 | |
| Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light Solar Protection Formula SPF® 60, Photobiological testing - High-grade Dysplasia in Barrett Esophagus, Non Small Cell Lung Cancer | Phase 2 | Withdrawn | Pinnacle Biologics Inc. | 2013-05-01 | 2014-03-04 | |
| Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy Norepinephrine - Radiodermatitis | Phase 1 / Phase 2 | Withdrawn | ProCertus BioPharm, Inc | 2012-03-01 | 2012-05-28 | |
| Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) Infliximab - Stevens-Johnson Syndrome, Corneal Blindness | Phase 1 / Phase 2 | Withdrawn | Massachusetts Eye and Ear Infirmary | 2010-12-01 | 2015-11-04 | |
| Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome henna paste - Hand Foot Skin Syndrome | Phase 2 | Withdrawn | Northwestern University | 2010-03-01 | 2014-12-12 | |
| A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) Roflumilast cream, Placebo cream - Dermatitis | Phase 2 | Withdrawn | AstraZeneca | 2008-11-01 | 2016-12-01 | |
| Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN) Remicaide (infliximab) - Toxic Epidermal Necrolysis | Phase 2 | Withdrawn | Loyola University | 2006-07-01 | 2013-04-26 |
Dermatitis, Atopic (8) · Stevens-Johnson Syndrome (4) · Pruritus (3) · Eczema (2) · Radiodermatitis (2) · Carcinoma, Non-Small-Cell Lung (1) · Dermatitis, Phototoxic (1) · Esophageal Neoplasms (1) · Hand-Foot Syndrome (1) · Pemphigoid, Benign Mucous Membrane (1) · Syndrome (1)
Skin Diseases (18) · Skin and Connective Tissue Diseases (18) · Hypersensitivity (12) · Immune System Diseases (12) · Skin Diseases, Eczematous (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Genetic Diseases, Inborn (8) · Hypersensitivity, Immediate (8) · Skin Diseases, Genetic (8) · Chemically-Induced Disorders (5) · Drug Eruptions (5) · Drug Hypersensitivity (5) · Drug-Related Side Effects and Adverse Reactions (5) · Erythema (4)
Infliximab (3) · Naltrexone (2) · Clobetasol (1) · Exercise (1) · Ivermectin (1) · Mometasone Furoate (1) · Norepinephrine (1) · Ointments (1) · orvepitant (1)
University of Minnesota (2) · AstraZeneca (1) · BiomX, Inc. (1) · Fuda Cancer Hospital, Guangzhou (1) · James Chodosh, MD, MPH (1) · Loyola University (1) · MYOR Ltd. (1) · Massachusetts Eye and Ear Infirmary (1) · Montefiore Medical Center (1) · Nerre Therapeutics Ltd. (1) · Northwestern University (1) · Pinnacle Biologics Inc. (1) · ProCertus BioPharm, Inc (1) · Santalis Pharmaceuticals, Inc. (1) · Stanford University (1)
United States (9) · Canada (1) · China (1)
James Chodosh, MD, MPH (2) · Paul Bigliardi, MD (2) · Claes H Dohlman, MD, PhD (1) · Eleanor Harris, MD (1) · Elena Fridman, MD (1) · Emanual Maverakis, MD (1) · Kavita Sarin, MD, PhD (1) · Lindsay Pattison (1) · Mona Harissi-Dagher, MD (1) · Peter Lio, MD (1) · Richard Gamelli, MD (1) · Richard L Gallo, MD, PhD (1) · Urania Rappo, MD (1) · Yana Kost (1)